These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 8329574

  • 1. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
    Puri RN, Colman RW.
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
    Matsueda R, Umeyama H, Puri RN, Bradford HN, Colman RW.
    Pept Res; 1994 Jun; 7(1):32-5. PubMed ID: 8019060
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of thrombin- and plasmin-induced platelet aggregation by a synthetic peptide disulfide.
    Puri RN, Hu CJ, Bradford HN, Matsueda R, Umeyama H, Colman RW.
    Trans Assoc Am Physicians; 1989 Jun; 102():13-9. PubMed ID: 2561638
    [Abstract] [Full Text] [Related]

  • 4. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
    Puri RN, Matsueda R, Umeyama H, Bradford HN, Colman RW.
    Eur J Biochem; 1993 May 15; 214(1):233-41. PubMed ID: 8389701
    [Abstract] [Full Text] [Related]

  • 5. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P, Hauert J, Iorio A, Callegari P, Agnelli G.
    J Lab Clin Med; 1995 Feb 15; 125(2):212-21. PubMed ID: 7531212
    [Abstract] [Full Text] [Related]

  • 6. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN, Hu CJ, Matsueda R, Umeyama H, Colman RW.
    Thromb Res; 1992 Mar 01; 65(4-5):533-47. PubMed ID: 1535463
    [Abstract] [Full Text] [Related]

  • 7. [Effect of thrombolytic agents on platelets and blood coagulation system].
    Suehiro A.
    Rinsho Byori; 1997 Oct 01; 45(10):951-6. PubMed ID: 9369072
    [Abstract] [Full Text] [Related]

  • 8. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
    Puri RN, Zhou FX, Colman RF, Colman RW.
    Am J Physiol; 1990 Dec 01; 259(6 Pt 1):C862-8. PubMed ID: 2148055
    [Abstract] [Full Text] [Related]

  • 9. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
    Thromb Haemost; 1997 Apr 01; 77(4):741-7. PubMed ID: 9134653
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 01; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 11. Characterization of plasmin-induced platelet aggregation.
    Watabe A, Ohta M, Matsuyama N, Mizuno K, el Borai N, Tanimoto T, Kawanishi T, Hayakawa T.
    Res Commun Mol Pathol Pharmacol; 1997 Jun 01; 96(3):341-52. PubMed ID: 9261893
    [Abstract] [Full Text] [Related]

  • 12. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D, Füredi R, Gecse K, Ghosh S, Falusi B, Bogár L, Roth E, Lantos J.
    Blood Coagul Fibrinolysis; 2007 Oct 01; 18(7):661-7. PubMed ID: 17890954
    [Abstract] [Full Text] [Related]

  • 13. [Peptides as inhibitors of thrombin coagulation activity and of thrombocyte aggregation].
    Pastorova VE, Liapina LA, Cherkasova KA, Ashmarin IP.
    Usp Fiziol Nauk; 1999 Oct 01; 30(2):80-91. PubMed ID: 10420478
    [Abstract] [Full Text] [Related]

  • 14. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
    Zhang L, Wang J, Yu M, Ru B.
    Mol Genet Metab; 2004 Aug 01; 82(4):304-11. PubMed ID: 15308128
    [Abstract] [Full Text] [Related]

  • 15. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE.
    Biochemistry; 1999 Apr 06; 38(14):4572-85. PubMed ID: 10194379
    [Abstract] [Full Text] [Related]

  • 16. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN, Zhou FX, Bradford H, Hu CJ, Colman RF, Colman RW.
    Arch Biochem Biophys; 1989 Jun 06; 271(2):346-58. PubMed ID: 2543293
    [Abstract] [Full Text] [Related]

  • 17. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R, Liang N.
    Cell Biol Int; 1998 Jun 06; 22(6):429-35. PubMed ID: 10328851
    [Abstract] [Full Text] [Related]

  • 18. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
    Murphey LJ, Malave HA, Petro J, Biaggioni I, Byrne DW, Vaughan DE, Luther JM, Pretorius M, Brown NJ.
    J Pharmacol Exp Ther; 2006 Sep 06; 318(3):1287-92. PubMed ID: 16772538
    [Abstract] [Full Text] [Related]

  • 19. SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis.
    Feigen LP, Nicholson NS, King LW, Campion JG, Tjoeng FS, Panzer-Knodle SG.
    J Pharmacol Exp Ther; 1993 Dec 06; 267(3):1191-7. PubMed ID: 8263779
    [Abstract] [Full Text] [Related]

  • 20. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
    Martínez C, Rivera J, Loyau S, Corral J, González-Conejero R, Lozano ML, Vicente V, Anglés-Cano E.
    Thromb Haemost; 2001 Apr 06; 85(4):686-93. PubMed ID: 11341506
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.